Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
about
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesThe role of comfort and discomfort in insulin therapyHealth disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statementThe longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary careExploring patient values in medical decision making: a qualitative studyDevelopment and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes.Performance of a new reusable insulin penPsychometric validation of the Self-Care Inventory-Revised (SCI-R) in UK adults with type 2 diabetes using data from the AT.LANTUS Follow-on study.Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study.Dose accuracy and injection force dynamics of a novel disposable insulin pen.An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocolFurther investigation of the psychometric properties of the Insulin Treatment Appraisal Scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from Diabetes MILES-Australia.The meaning of insulin to Hispanic immigrants with type 2 diabetes and their families.Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)Identifying and meeting the challenges of insulin therapy in type 2 diabetes.Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes.Factors associated with psychological insulin resistance in individuals with type 2 diabetes.Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative studyInitiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients' and health professionals' experiences.A qualitative study on healthcare professionals' perceived barriers to insulin initiation in a multi-ethnic population.Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study.Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.A review of the pharmacological properties of insulin degludec and their clinical relevance.Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration.Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatmentChallenges of maintaining research protocol fidelity in a clinical care setting: a qualitative study of the experiences and views of patients and staff participating in a randomized controlled trialDevelopment and validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for primary care patients with type 2 diabetesThe multinational second Diabetes, Attitudes, Wishes and Needs study: results of the French surveyEffect of an experiential exercise in diabetes management on pharmacy students' fear and perceived pain of injection and fingertip lancing.New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).Insulin therapy refusal among type II diabetes mellitus patients in Kubang Pasu district, the state of Kedah, Malaysia.Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy.Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trial.
P2860
Q26741537-D2C418CF-9A08-49D9-87C3-190B67DD5695Q26861313-E0F83E93-7EFB-4441-95EF-91E356375EA3Q27015671-BD203FED-11D3-4636-A3E2-2E4415028DD6Q28388174-F3BE8525-3EB6-4D5D-B703-738AB8C81C81Q28534790-F8266F93-22E5-4F11-99AC-4A276BBF0207Q30356101-3F8C778C-8A3A-4FA7-AFBE-8C22A9C83A73Q30481274-5D489CCF-F4DC-41E8-9A08-AD92814F5955Q30500629-39741F92-3711-48BB-BFDA-578D41E52F58Q30538061-ACDBE232-F2F2-4D4A-A050-5899BFE0C433Q33254077-94A5859E-0A5C-425C-ACF5-CE3DCA405847Q33276648-FB2805FE-0BB3-401C-9B90-CD3A05F5251DQ33680901-AFF24292-6572-465F-93A3-A9996418A58DQ33729867-8E782543-C228-4411-8848-6AC279A335EBQ33745909-574F26CA-F6D8-4027-A6A6-76FC26D9A0A2Q33751437-0E3912E1-9198-49C3-AB37-37E5D513D7CFQ33791586-A0A4D027-2877-44DD-921C-E7365A96CA66Q33797394-81C93F58-B5F3-4277-B455-B46671CB3F0BQ33863413-B1F78317-6488-4F9F-A289-7212F286182AQ33979653-B69FFB3B-828E-4D85-AF60-C7B153871D35Q33996818-12E8A3B7-378A-4220-A0E6-028A7B4C5F9CQ34015994-B067BB7B-1CD7-4512-BA5A-F000BC96A093Q34041978-4D268F6C-93AC-45C6-9997-B4698388D8C5Q34153449-DBB8D463-C3C3-4B6B-BFFC-20DA981DE121Q34216946-9AF615F9-F124-4085-A4EB-6713F68FF938Q34222009-0D13B2DB-247B-413C-9299-DA4117305EDEQ34238821-850FF9C6-E659-4E2A-97D5-757D80BA44EAQ34436383-F5C0AAD2-3B11-4DEB-82EF-CF583D4AF43BQ34509377-63AD7FF6-3DC7-4D35-B6BA-AEC001DC1257Q34553412-9B423777-E37E-447B-936B-4CA0B2C32C0DQ34558840-3DD2BBFC-289C-4C0B-9A06-4DC9BD47EB04Q34981168-24EB1B9B-A66E-4F85-B115-2DD39490A4A5Q35001542-B4A0C003-DCB5-4EE1-B6D9-7C42E003E8A3Q35014936-3B6A4A93-8BCC-4688-A039-A932CF6532CDQ35043641-E9EE520A-0758-4BF6-8C89-0AF2D9F7D505Q35101008-D51D8B16-6CCB-4C98-BF30-8374810EBDABQ35138786-20120120-6968-47A2-848D-C0036284530EQ35538347-B64CB41C-7231-4470-A2A8-7C560C9DDD7DQ35555349-9043CE88-10AA-4A58-AEF7-5914D40792CDQ35691530-902CC36A-0C16-4A8C-B3A9-979A2AC15939Q35694576-D1B42F42-89E8-4F2A-A966-9A42D080882D
P2860
Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Psychological insulin resistan ...... tes: the scope of the problem.
@en
Psychological insulin resistan ...... tes: the scope of the problem.
@nl
type
label
Psychological insulin resistan ...... tes: the scope of the problem.
@en
Psychological insulin resistan ...... tes: the scope of the problem.
@nl
prefLabel
Psychological insulin resistan ...... tes: the scope of the problem.
@en
Psychological insulin resistan ...... tes: the scope of the problem.
@nl
P2093
P921
P1433
P1476
Psychological insulin resistan ...... tes: the scope of the problem.
@en
P2093
Lawrence Fisher
Leonel Villa-Caballero
Steven V Edelman
Susan Guzman
William H Polonsky
P304
P356
10.2337/DIACARE.28.10.2543
P407
P577
2005-10-01T00:00:00Z